Skip to main content
. 2017 Jan 18;3:121. doi: 10.3389/fvets.2016.00121

Table 3.

Percentage means of mesenchymal stem cells (MSCs) from bone marrow (BM) and synovial fluid (SF) of the same donor for the CD90, CD29, CD44, CD34, and major histocompatibility complex II (MHC-II) markers by flow cytometry.

Donors CD90 CD29 CD44 CD34 MHC-II
Bone marrow-derived mesenchymal stem cells (BMMSCs) donor 1 95.55 ± 0.55 75.6 ± 3 96.6 ± 0 1.15 ± 0.85 0.28 ± 0
Synovial fluid-derived mesenchymal stem cells (SFMSCs) donor 1 83.35 ± 2.35 90.55 ± 1.65 91.5 ± 4.5 0.95 ± 0.75 3.245 ± 2.65
BMMSCs donor 2 90.95 ± 4.35 65.95 ± 7.3 99.1 ± 0 1.05 ± 0.05 1.36 ± 0.36
SFMSCs donor 2 76.3 ± 6 71.55 ± 6.75 94.25 ± 1.25 1.45 ± 0.35 7.805 ± 5.1
BMMSCs donor 3 97.25 ± 2.55 86.35 ± 12.15 92.65 ± 7.3 0.635 ± 0.36 1.85 ± 0.45
SFMSCs donor 3 98.9 ± 0.5 99.75 ± 0.25 99.9 ± 0 10.25 ± 0.25 10.2 ± 0.8
BMMSCs donor 4 86.15 ± 0.65 98.8 ± 0.85 99.9 ± 0.1 0.15 ± 0.05 1.75 ± 0.65
SFMSCs donor 4 95.3 ± 0.1 98.8 ± 0.8 99.4 ± 0.4 1.72 ± 0.02 6.15 ± 1.4
BMMSCs donor 5 99.9 ± 0.05 99.6 ± 0.1 99.8 ± 0 3.5 ± 0.3 4.1 ± 0.9
SFMSCs donor 5 96.4 ± 2.8 99.4 ± 0.1 99.7 ± 0.05 0.99 ± 0.5 21 ± 6